Phillip Chappell
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 20, 2025
Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of Safety.Sara Ramaker, Francesca Kolitsopoulos, Lisa Ludwig
|Feb 16, 2024
A randomized, double-blind, dose-controlled study of the use of dexmedetomidine alone for procedural sedation of children and adolescents undergoing MRI scans.Umar Khan, Gregory B Hammer, Cassandra Duncan-Azadi
|Feb 13, 2024
Response to Chadi A. Calarge re: "Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)".Francesca Kolitsopoulos, Sara Ramaker, Philip Chappell
|Feb 17, 2023
Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES).Francesca Kolitsopoulos, Sara Ramaker, Scott N Compton
|Oct 25, 2022
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic).Sarah Atkinson, Mary Bachinsky, Yaron Raiter
|Apr 08, 2022
Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study.Robert L Findling, Sarah Atkinson, Mary Bachinsky
Pageof 1
